# Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients

> **NCT05254821** · — · UNKNOWN · sponsor: **Federico II University** · enrollment: 130 (estimated)

## Conditions studied

- Hodgkin Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05254821
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-10
- **Primary completion:** 2024-02-03
- **Final completion:** 2026-02-03
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2022-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05254821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05254821, "Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT05254821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*